Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Fuso Pharmaceutical Industries,Ltd. ( (JP:4538) ) has issued an update.
Fuso Pharmaceutical Industries, Ltd. has announced its medium-term management plan, FUSO VISION 2030 Next Stage, aimed at addressing industry challenges and ensuring sustainable growth. The plan includes significant investments in production facilities, research and development, and digital transformation to enhance corporate value and meet unmet medical needs. The company aims to achieve sales of over 70 billion yen and an ROE of over 8.0% by 2030, despite expected profit declines until 2028 due to initial investments.
More about Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries, Ltd. operates in the pharmaceutical industry, focusing on the production of basic pharmaceutical products. The company prioritizes the stable supply of medicines essential for healthcare, with a market focus on dialysis supplies, kidney and urinary system products, and infertility treatment solutions.
Average Trading Volume: 17,054
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen19.61B
See more data about 4538 stock on TipRanks’ Stock Analysis page.